MedTrace Logo

Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy

NCT02007122 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-04-14

No results posted yet for this study

Summary

The study will be conducted to investigate the pharmacokinetics of ceftaroline during continuous and intermittent renal replacement therapy.

Conditions

  • Infection During Renal Replacement Therapy

Interventions

OTHER

Ceftaroline in CRRT

Plasma levels of ceftaroline will be measured in patients receiving CRRT

OTHER

Ceftaroline in IRRT

Ceftaroline plasma levels will be measured in patients receiving intermittent renal replacement therapy

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2022-11-30
Completion
2023-03-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007122 on ClinicalTrials.gov